ONCOLYTICS BIOTECH INC
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus… (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-13 | Kelly Jared | Director & Chief Executive Officer | Purchase | 5,050 | $0.96 | $5K | 114.0K | View | |
| 2026-03-11 | 2026-03-13 | Parsons James T. | Director | Purchase | 10.0K | $1.03 | $10K | 41.8K | View | |
| 2026-02-12 | 2026-02-13 | Look Kirk | Chief Financial Officer | Purchase | 12.0K | $0.84 | $10K | 287.5K | View | |
| 2026-02-12 | 2026-02-13 | Pisano Wayne | Director | Purchase | 30.0K | $0.84 | $25K | 492.4K | View | |
| 2026-02-12 | 2026-02-13 | Heineman Thomas Charles | Chief Medical Officer | Purchase | 12.1K | $0.83 | $10K | 282.8K | View |
Informational purposes only, not investment advice.
tormere.com/research/ONCY · generated 2026-11-04
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus…
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-12 | Kelly Jared | P | 5,050 | $4,848 |
| 2026-03-11 | Parsons James T. | P | 10,000 | $10,300 |
| 2026-02-12 | Look Kirk | P | 12,000 | $10,104 |
| 2026-02-12 | Pisano Wayne | P | 30,000 | $25,338 |
| 2026-02-12 | Heineman Thomas Charles | P | 12,132 | $10,033.16 |
Tormere — informational purposes only, not investment advice.
| Filed | Items | Filing |
|---|---|---|
Oct 27, 2026 accepted 9:46 AM ET | 8.01Other events | DocumentSEC ↗ |
Oct 20, 2026 accepted 9:37 AM ET | 8.01Other events | DocumentSEC ↗ |
Oct 14, 2026 accepted 9:33 AM ET | 8.01Other events | DocumentSEC ↗ |
Oct 13, 2026 accepted 8:10 AM ET | 8.01Other events | DocumentSEC ↗ |
Sep 29, 2026 accepted 9:34 AM ET | 8.01Other events | DocumentSEC ↗ |
Sep 28, 2026 accepted 9:32 AM ET | 8.01Other events | DocumentSEC ↗ |
Sep 10, 2026 accepted 8:17 AM ET | 8.01Other events | DocumentSEC ↗ |
Aug 18, 2026 accepted 9:03 AM ET | 8.01Other events | DocumentSEC ↗ |
Jul 24, 2026 accepted 4:40 PM ET | 3.01Delisting notice | DocumentSEC ↗ |
Jul 20, 2026 accepted 9:03 AM ET | 8.01Other events | DocumentSEC ↗ |